Amyloid arthropathy associated with multiple myeloma: a systematic analysis of 101 reported cases

Ahmed M Elsaman1, Ahmed R Radwan, Manas K Akmatov

  • 1Department of Rheumatology and Rehabilitation, Sohag University, Sohag, Egypt.

Abstract

Insights

Multiple myeloma (MM) can cause joint pain and swelling that mimics rheumatoid arthritis (RA). This study analyzed 101 cases, highlighting MM arthropathy as a diverse and often under-recognized presenting symptom.

Area of Science:

  • Rheumatology
  • Hematology
  • Medical Research

Background:

  • Multiple myeloma (MM) can present with amyloid deposition, potentially leading to arthropathy that mimics rheumatoid arthritis (RA).
  • A systematic description of the natural history of MM-associated arthropathy is lacking.
  • This study systematically analyzes published cases to describe the characteristics and presentation of MM arthropathy.

Purpose of the Study:

  • To systematically analyze published cases of multiple myeloma (MM) with associated arthropathy.
  • To describe the natural history, clinical manifestations, and diagnostic features of MM arthropathy.
  • To emphasize the importance of recognizing arthropathy as a potential presenting sign of MM.

Main Methods:

  • Comprehensive literature review using backward and forward database searches and reference list inspection.
  • Inclusion criteria: publication between 1931-2012, confirmed MM diagnosis, and evidence of light chain amyloid (AL) or arthritis/synovitis.
  • Analysis of 101 identified cases, focusing on demographics, systemic MM manifestations, arthritis presentation, joint involvement, synovial fluid analysis, and imaging findings.

Main Results:

  • 101 cases of MM arthropathy were identified, with a median age of 59 and a 1:1 male-to-female ratio.
  • Arthritis preceded MM diagnosis in 63 cases, with 33 initially misdiagnosed as RA. The shoulder was the most commonly affected joint.
  • Synovial histopathology often showed mild synovitis without plasma cell infiltration, and imaging revealed inflammation and bone lesions in a subset of cases.

Conclusions:

  • MM arthropathy typically presents as a symmetric, rheumatoid factor-negative, nonerosive polyarthritis.
  • The diverse clinical presentations underscore the need to consider arthropathy as a potentially under-recognized initial manifestation of MM.
  • Early recognition of MM-associated arthropathy is crucial for timely diagnosis and management of multiple myeloma.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...